Stada takes €300m but cannot tighten price
Stada, the unrated German generic and branded drugs maker, issued a €300m seven year bond on Tuesday, but failed to tighten the pricing, in tough market conditions.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
- ✔ 4,000 annual insights
- ✔ 700+ notes and long-form analyses
- ✔ 4 capital markets databases
- ✔ Daily newsletters across markets and asset classes
- ✔ 2 weekly podcasts
